Are natural killer cells protecting the metabolically healthy obese patient?

Obesity

Volumn 17, Issue 3, 2009, Pages 601-605

  Lynch, Lydia A ^a   O'Connell, Jean M ^a   Kwasnik, Anna K ^a   Cawood, Thomas J ^a   O'Farrelly, Cliona ^b   O'Shea, Donal B ^a,c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c St Columcille s Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; IMMUNE SYSTEM; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; T-LYMPHOCYTES, CYTOTOXIC; YOUNG ADULT;

EID: 60849138419     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.565     Document Type: Article

References (27)

1. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM. Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Med Wkly 2007;137:50-56.
2. Renehan G, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
3. Adams TD, Gress RE, Smith SC et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-761.
4. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism 2001;50:1499-1504.
5. Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
6. Brachu M, Tchernof A, Dionne IJ et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
7. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005;13:1116-1122.
8. Kim JH, Lim YJ, Kim YH et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16: 1543-1546.
9. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006;13:279-292.
10. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36.
11. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119.
12. Hotamisligll GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.
13. Scott P, Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 1995;7:34-40.
14. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:117-121.
15. Mori A, Sakurai H, Choo MK et al. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer 2006;119:2760-2767.
16. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007;137:1236-1243.
17. Bevan MJ. Helping the CD8+ T cell response. Nat Rev Immunol 2004;4: 595-602.
18. McLaughlin T, Reaven G, Abbasi F et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005;96:399-404.
19. Kirwan SE, Burshtyn DN. Regulation of natural killer cell activity. Curr Opin Immunol 2007;19:46-54.
20. Roda JM, Parihar R, Magro C et al. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res 2006;66:517-526.
21. O'Rourke RW, Kay T, Scholz MH et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 2005;15: 1463-1468.
22. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-393.
23. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 2006;117:1-10.
24. Fry AM, Lanier LL, Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 1996; 184: 295-300.
25. Tanaka J, Kobayashi S, Mori A et al. NK cells expressing killer cell inhibitory receptors after allogeneic bone marrow transplantation. Transplant Proc 2000;32:2447.
26. Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol 2005;42:485-488.
27. Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.